{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT03239535",
      "OrgStudyIdInfo": {
        "OrgStudyId": "MSC-CLI/FMBA/001"
      },
      "Organization": {
        "OrgFullName": "Federal Research Clinical Center of Federal Medical & Biological Agency, Russia",
        "OrgClass": "OTHER_GOV"
      },
      "BriefTitle": "Allogeneic Mesenchymal Stem Cells for the Critical Limb Ischemia Therapy",
      "OfficialTitle": "Allogeneic Mesenchymal Stem Cells for the Critical Limb Ischemia Therapy"
    },
    "StatusModule": {
      "StatusVerifiedDate": "August 2017",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "October 1, 2013",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "August 1, 2018",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "November 1, 2018",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "July 20, 2017",
      "StudyFirstSubmitQCDate": "August 1, 2017",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "August 4, 2017",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "August 1, 2017",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "August 4, 2017",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Federal Research Clinical Center of Federal Medical & Biological Agency, Russia",
        "LeadSponsorClass": "OTHER_GOV"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No",
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "The clinical trial aims to study the safety and efficacy of adult allogeneic mesenchymal stem cells for the treatment of critical limb ischemia."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Critical Limb Ischemia"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Non-Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "Single",
          "DesignWhoMaskedList": {
            "DesignWhoMasked": [
              "Participant"
            ]
          }
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "40",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Mesenchymal stem cells",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Mesenchymal stem cells, Intramuscular injection",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Mesenchymal stem cells"
              ]
            }
          },
          {
            "ArmGroupLabel": "Normal saline",
            "ArmGroupType": "Placebo Comparator",
            "ArmGroupDescription": "Normal saline, Intramuscular injection",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Normal saline"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Mesenchymal stem cells",
            "InterventionDescription": "Intramuscular injection",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Mesenchymal stem cells"
              ]
            }
          },
          {
            "InterventionType": "Biological",
            "InterventionName": "Normal saline",
            "InterventionDescription": "Intramuscular injection",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Normal saline"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Adverse events",
            "PrimaryOutcomeDescription": "Number of adverse events reported",
            "PrimaryOutcomeTimeFrame": "24 months"
          },
          {
            "PrimaryOutcomeMeasure": "Amputation-free survival",
            "PrimaryOutcomeDescription": "Number of survived patients",
            "PrimaryOutcomeTimeFrame": "24 months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Limb salvage from major amputation",
            "SecondaryOutcomeDescription": "Number of patients who avoided amputation",
            "SecondaryOutcomeTimeFrame": "3, 6, 12, 24 months"
          },
          {
            "SecondaryOutcomeMeasure": "Relief of the rest pain",
            "SecondaryOutcomeDescription": "Rest pain will be measured using the rest pain scale",
            "SecondaryOutcomeTimeFrame": "Immediate, 3, 6, 12, 24 months"
          },
          {
            "SecondaryOutcomeMeasure": "Improvement in healing trophic disorders",
            "SecondaryOutcomeDescription": "Assessment of the severity of trophic ulcers",
            "SecondaryOutcomeTimeFrame": "Immediate, 3, 6, 12, 24 months"
          },
          {
            "SecondaryOutcomeMeasure": "Improvement in perfusion by the ankle-brachial index",
            "SecondaryOutcomeDescription": "Measurements of the ankle-brachial index",
            "SecondaryOutcomeTimeFrame": "Immediate, 3, 6, 12, 24 months"
          },
          {
            "SecondaryOutcomeMeasure": "Improvement in perfusion by radioisotope scintigraphy",
            "SecondaryOutcomeDescription": "Radioisotope scintigraphy study",
            "SecondaryOutcomeTimeFrame": "Immediate, 3, 6, 12, 24 months"
          },
          {
            "SecondaryOutcomeMeasure": "Improvement in total walking distance (TWD) using a standard treadmill test",
            "SecondaryOutcomeDescription": "Standard treadmill test",
            "SecondaryOutcomeTimeFrame": "Immediate, 3, 6, 12, 24 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nMales or females in the age group of 18-80 yrs of Caucasian origin.\nPeripheral artery disease (PAD) against the background of atherosclerosis and diabetes mellitus (DM)\nCritical lower limb ischemia (stages 3-4 by Fontaine-Pokrovsky or stages 4-6 by Rutherford)\nPatients with remaining symptoms of critical limb ischemia (CLI) in spite of the performed surgical (endovascular or open) treatment and continuing conservative therapy\nPatients with absent emergency indications to major amputation\nPatients planned for the reconstructive surgery with a questionable remote outcome due to compromised blood outflow\nAnkle Brachial Pressure Index (ABPI) ≤ 0.5 or ankle pressure ≤ 70 mm Hg\nPatients, if having associated Type II Diabetes, should be on medication and well controlled (HbA1c ≤ 8.5 %)\nOn regular medication for hypertension if needed\nNormal liver and renal function (or having clinically insignificant deviations, according to the treating physician's opinion)\nPatients who are able to understand the requirements of the study, and willing to provide voluntary written informed consent, abide by the study requirements, and agree to return for required follow-up visits\n\nExclusion Criteria:\n\nHumid gangrene or acute/chronic infection of lower limb.\nDry gangrene with extensive foot lesion (> 1\\2).\nAcute arterial failure.\nLife-threatening conditions and predicted life expectancy of < 6 months.\nPresence of neoplasm or bone marrow disease\nSigns of active or chronic, including latent, haemorrhage\nAny acute or chronic infectious disease\nRenal failure determined as twofold or higher elevation of serum creatinine as compared to the upper normal limit\nHepatic failure determined as the bilirubin, alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels elevated by two and more times over the upper normal limits\nThrombocytopenia (platelet counts < 50,000 /µl), leukocytopenia (WBC < 4,000/µl), immunosuppressive therapy\nPronounced neurological deficit\nPatients with gait disturbance for reasons other than CLI\nPatients not suitable for cell therapy, by the treating physician's opinion\nCLI patients requiring amputation at the proximal to the trans-metatarsal level\nPatients with Type I diabetes\nPatients having respiratory complications/left ventricular ejection fraction < 25%\nStroke or myocardial infarction within last 3 months\nPatients who are contraindicated for X-ray angiography\nHistory of severe alcohol or drug abuse within 3 months of screening\nPregnant and lactating women.\nPatients tested positive for HIV 1, hepatitis C virus (HCV), hepatitis B virus (HBV)\nUnsigned informed consent",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "80 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Mikhail A Konoplyannikov, PhD",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "+79154027268",
            "CentralContactEMail": "mkonopl@mail.ru"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Vladimir P Baklaushev, MD, PhD",
            "OverallOfficialAffiliation": "Deputy Director",
            "OverallOfficialRole": "Study Director"
          },
          {
            "OverallOfficialName": "Pavel Yu Orekhov, MD, PhD",
            "OverallOfficialAffiliation": "Vascular Surgeon",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Federal Research Clinical Center of Federal Medical & Biological Agency",
            "LocationStatus": "Recruiting",
            "LocationCity": "Moscow",
            "LocationCountry": "Russian Federation",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Mikhail A Konoplyannikov, PhD",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "+79154027268",
                  "LocationContactEMail": "mkonopl@mail.ru"
                }
              ]
            }
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "No"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000007511",
            "ConditionMeshTerm": "Ischemia"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M9695",
            "ConditionBrowseLeafName": "Ischemia",
            "ConditionBrowseLeafAsFound": "Ischemia",
            "ConditionBrowseLeafRelevance": "high"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          }
        ]
      }
    }
  }
}